Liberty Mutual Group Asset Management’s 10x Genomics TXG Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,216	Closed	-$553K	–	130
2022 Q2	$553K	Sell	12,216 -32,524	-73%	-$1.69M	0.08%	107
2022 Q1	$3.4M	Buy	44,740 +36,931	+473%	+$3.23M	0.12%	59
2021 Q4	$1.16M	Buy	+7,809	New	+$1.2M	0.06%	42
2021 Q2	–	Sell	-7,029	Closed	-$1.27M	–	25
2021 Q1	$1.27M	Buy	+7,029	New	+$1.21M	0.08%	14
2020 Q4	–	Sell	-8,739	Closed	-$1.09M	–	15
2020 Q3	$1.09M	Buy	+8,739	New	+$917K	0.13%	9

Other funds holding TXG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

SIM

SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Liberty Mutual Group Asset Management's TXG Position: Q3 2022 in Review

Liberty Mutual Group Asset Management sold out of 10x Genomics (TXG) in Q3 2022, closing a stake of 12,216 shares — an estimated $553K sold.

Liberty Mutual Group Asset Management first reported a position in TXG in Q3 2020 and held it in 5 quarters. The position peaked at $3.4M in Q1 2022. 233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

Liberty Mutual Group Asset Management reported no remaining 10x Genomics position as of Q3 2022 after selling out during the quarter.
Liberty Mutual Group Asset Management sold 12,216 10x Genomics shares in Q3 2022, an estimated $553K.
Liberty Mutual Group Asset Management first reported a position in 10x Genomics in Q3 2020 and held it in 5 quarters.
Liberty Mutual Group Asset Management's 10x Genomics position peaked at $3.4M in Q1 2022.
233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on Liberty Mutual Group Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.